Geneva Partners’s Ingredion INGR Stock Holding History

Geneva Partners’s Portfolio INGR Stock Details INGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,815	Closed	-$298K	–	71
2023 Q2	$298K	Buy	+2,815	New	+$299K	0.19%	63

Other funds holding INGR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

YAM

Yacktman Asset Management Austin, Texas $8.09B AUM 19.03% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Geneva Partners's INGR Position: Q3 2023 in Review

Geneva Partners sold out of Ingredion (INGR) in Q3 2023, closing a stake of 2,815 shares — an estimated $298K sold.

Geneva Partners first reported a position in INGR in Q2 2023 and held it in 1 quarter. The position peaked at $298K in Q2 2023. 482 funds tracked by Wall St. Rank hold INGR as of Q3 2023.

Geneva Partners reported no remaining Ingredion position as of Q3 2023 after selling out during the quarter.
Geneva Partners sold 2,815 Ingredion shares in Q3 2023, an estimated $298K.
Geneva Partners first reported a position in Ingredion in Q2 2023 and held it in 1 quarter.
Geneva Partners's Ingredion position peaked at $298K in Q2 2023.
482 funds tracked by Wall St. Rank held Ingredion as of Q3 2023.

Based on Geneva Partners's 13F filing for Q3 2023, filed 25 Oct 2023.